Javascript must be enabled to continue!
Pattern Recognition Methods for Acute Myeloid Leukemia (AML) Induction-Treatment Analysis
View through CrossRef
Acute Myeloid Leukemia is a neoplastic malignancy, which originate from the myeloid line of the cells of hematopoietic system. Although it is a relatively rare cancer and despite of improvement in prognosis due to recent radio-chemotherapy regimens, it is still a severe disease and only a minority of patients are cured. In the present work we propose a methodological approach, evaluating and benchmarking different supervised learning techniques for the prediction of response to induction treatment in Acute Myeloid Leukemia (AML). Our research also focuses on the examination of the most significant indicators that contribute to the improvement of diagnosis.
Title: Pattern Recognition Methods for Acute Myeloid Leukemia (AML) Induction-Treatment Analysis
Description:
Acute Myeloid Leukemia is a neoplastic malignancy, which originate from the myeloid line of the cells of hematopoietic system.
Although it is a relatively rare cancer and despite of improvement in prognosis due to recent radio-chemotherapy regimens, it is still a severe disease and only a minority of patients are cured.
In the present work we propose a methodological approach, evaluating and benchmarking different supervised learning techniques for the prediction of response to induction treatment in Acute Myeloid Leukemia (AML).
Our research also focuses on the examination of the most significant indicators that contribute to the improvement of diagnosis.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Categorizing Molecular Mutations in MDS and AML
Categorizing Molecular Mutations in MDS and AML
Abstract
Introduction:
A huge amount of data on genetic alterations has been compiled by high throughput sequencing studies in several hematologic mal...
Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function
Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function
Abstract
Abstract 3140
Immunotherapies, including stimulating patients' immune system with acute myeloid leukemia (AML)-derived dendritic cell (DC) va...
Abstract 6869: Paired single-cell B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cell immunity in acute myeloid leukemia
Abstract 6869: Paired single-cell B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cell immunity in acute myeloid leukemia
Abstract
Acute myeloid leukemia (AML) is the second most common adult leukemia with a five-year survival rate around 30%. For decades, AML treatment has centered aro...
Early Occurrence of Therapy-Related Acute Myeloid Leukemia (t-AML) with Monocytic Differentiation with Trisomy 8 Cytogenetic Abnormality after Radioactive Iodine (RAI) Treatment for Papillary Thyroid Cancer
Early Occurrence of Therapy-Related Acute Myeloid Leukemia (t-AML) with Monocytic Differentiation with Trisomy 8 Cytogenetic Abnormality after Radioactive Iodine (RAI) Treatment for Papillary Thyroid Cancer
Abstract
Background: Although most t-AML occurs after chemotherapy +/- radiation, exposure to radioactive substances can be implicated, as in nuclear accidents. Thyr...
Low miR‐34c expression is associated with poor outcome in de novo acute myeloid leukemia
Low miR‐34c expression is associated with poor outcome in de novo acute myeloid leukemia
SummaryIntroductionMicroRNA‐34c (miR‐34c) has been found to play important roles in tumorigenesis. However, little is known about miR‐34c expression and the impact on prognosis in ...
Myosin-IIa Is Required for Leukemia Cell Extravasation and Its Inhibition Reduces Leukemia Dissemination and Prolongs Survival in a Mouse Model of Acute Lymphoblastic Leukemia
Myosin-IIa Is Required for Leukemia Cell Extravasation and Its Inhibition Reduces Leukemia Dissemination and Prolongs Survival in a Mouse Model of Acute Lymphoblastic Leukemia
Abstract
Background: Leukemia affects approximately 45,000 people each year in the USA with more than 20,000 fatalities. Many leukemia patients experience initial re...
Mutational Frequency in Hispanic Vs. Non-Hispanic Patients with Acute Myeloid Leukemia (AML)
Mutational Frequency in Hispanic Vs. Non-Hispanic Patients with Acute Myeloid Leukemia (AML)
Abstract
Introduction: There is a paucity of data on the distribution of acute leukemia (AL) across ethnic groups. Historically, B-cell acute lymphoblastic leukemia ...

